Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses.
Coinfection with other hepatitis viruses modifies the viral profile in serum and leads to more liver damage and more rapid progression during the course of hepatitis C virus infection. The viral interference is not only carried out by virus-virus or by virus-cell interactions but also by an enhanced immune response. A superinfecting viral infection does not crossactivate protective immune responses to the pre-existing virus albeit the latter can become undetectable. The induced cytokine stimulation might enhance the hepatic inflammation. Moreover, hepatitis B virus coinfection increases the risk of development of hepatocellular carcinoma in hepatitis C virus patients through common necro-inflammatory pathways or by direct oncogenic activity of hepatitis B virus. Viral interaction also complicates the management of the coinfection because hepatitis C virus impairs the humoral response to hepatitis A virus and hepatitis B virus vaccines, and because pharmacological suppression of hepatitis C virus endangers dually infected patients with reactivation of coinfected hepatitis B virus. Optimized strategies and follow-up are thus necessary in the treatment of infection with multiple viruses. It seems thus necessary to look for markers of hepatitis B virus and/or hepatitis D virus infection in chronic hepatitis patients positive for hepatitis C virus antibodies but negative for hepatitis C virus RNA, and equally well to search for hepatitis C virus RNA in HBsAg-negative/anti-HBc-positive patients with a low level of serum hepatitis B virus DNA.
Lin
Lan
L
Department of Hepatology, University Hospital Gasthuisberg, Leuven, Belgium.
Verslype
Chris
C
van Pelt
Jos F
JF
van Ranst
Marc
M
Fevery
Johan
J
D000818:Animals; D016207:Cytokines / Q000096:biosynthesis; D005814:Genes, Viral; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology; D006509:Hepatitis B / Q000150:complications / Q000276:immunology / Q000821:virology; D006515:Hepatitis B virus / Q000235:genetics / Q000502:physiology; D006526:Hepatitis C / Q000150:complications* / Q000276:immunology / Q000821:virology; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000276:immunology / Q000821:virology; D006801:Humans; D009154:Mutation
D016207:Cytokines